Search Tips
of 1 Next >
Results Found: 3
  • A paracrine IGF1/IGF1R-PI3K signaling loop underlies resistance to CSF-1R inhibition in GBM

    Authors
    Bowman, Robert L.
    Quail, Daniela F.
    Joyce, Johanna A.
    Description

    Summary from GEO: "Glioblastoma multiforme (GBM) is the most aggressive form of glioma, and is notorious for its terminal prognosis and lack of responsiveness to current treatment approaches. The brain tumor microenvironment (TME) represents a largely untapped reservoir of therapeutic target options in GBM. Here we have focused on the interplay between glioma cells and tumor-associated macrophages/...

    Subject
    Drug Therapy, Combination
    Glioblastoma
    Macrophages
    Neoplasm Recurrence, Local
    Phosphoinositide-3 Kinase Inhibitors
    Receptor, IGF Type 1
    Tumor Microenvironment
    Access Rights
    Free to All
  • Microenvironment-driven IGF-1R/PI3K signaling underlies acquired resistance to CSF1R inhibition in gliomas (CGH)

    Authors
    Bowman, Robert L.
    Quail, Daniela F.
    Schuhmacher, Alberto J.
    Joyce, Johanna A.
    Description

    Summary form GEO: "Macrophages accumulate with glioblastoma multiforme (GBM) progression, and can be acutely targeted via inhibition of colony stimulating factor-1 receptor (CSF-1R) to regress high-grade tumors in animal models. However, whether and how resistance emerges in response to sustained CSF-1R blockade is unknown. Here, we investigate whether long-term CSF-1R inhibition can stably regress...

    Subject
    Drug Therapy, Combination
    Glioblastoma
    Macrophages
    Neoplasm Recurrence, Local
    Phosphoinositide-3 Kinase Inhibitors
    Receptor, IGF Type 1
    Tumor Microenvironment
    Access Rights
    Free to All
  • clonealign: 10X genomics chromium single-cell RNA-sequencing

    Description

    Description from EGA: "10X genomics chromium single-cell RNA-sequencing of (i) patient derived triple negative breast cancer xenograft (ii) primary tumour and ascites ovarian cancer cell lines at tumour recurrence."

    Subject
    Breast Neoplasms
    Genomics
    Neoplasm Recurrence, Local
    Ovarian Neoplasms
    RNA-Seq
    Access Rights
    Application Required